SHARE EXCHANGE AGREEMENT


BY AND BETWEEN


GH CAPITAL, INC.


AND


VITANA-X, INC.


 


THIS SHARE EXCHANGE AGREEMENT (the “Agreement”)
is made as of the 21st day of August 2019, between GH CAPITAL, INC., a Florida corporation (“GHHC”) and
the shareholders of VITANA-X, INC., a Florida Corporation (the shareholders are referred to collectively as “SELLERS”
and Vitana-X, Inc. is referred to as “Vitana-X”).


 


RECITALS


 


WHEREAS, the SELLERS collectively own 100%
of the shares of Vitana-X as set forth in the attached Schedule 1.1;


 


WHEREAS, GHHC presently has one million (1,000,000)
shares of Series B Preferred stock authorized, of which there are zero (0) shares issued and outstanding;


 


WHEREAS, the Board of Directors of GHHC desires
to reorganize GHHC by causing it to issue to SELLERS one million (1,000,000) shares of GHHC Series B Preferred stock in exchange
for SELLERS' transfer of their 100% of the issued and outstanding shares of Vitana-X to GHHC (the “Share Exchange”),
upon the terms, provisions, and conditions and for the consideration hereinafter set forth, thereby making Vitana-X a subsidiary
of GHHC; and


 


WHEREAS, the parties intend that the exchange
of stock qualifies as a tax-free reorganization under section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”),
and that the business combination contemplated hereby be accounted for as a reverse acquisition under the purchase method for business
combinations. The combination of the two companies is recorded as a recapitalization of Vitana-X, pursuant to which Vitana-X is
treated as the continuing entity.


 


AGREEMENT


 


NOW THEREFORE, in consideration of these premises
and the mutual agreements set forth below, intending to be legally bound, the parties agree as follows:


 


ARTICLE I


 


SHARE EXCHANGE


 


SECTION 1.1 EXCHANGE AND ISSUE OF SHARES.
On the terms and subject to the conditions here set forth, at the Closing,


 


		(a)	GHHC will issue and deliver one million (1,000,000) validly issued,
fully-paid and non-assessable shares of GHHC Series B Preferred Stock, having no par value per share, to the SELLERS on a pro rata
basis as set forth in Schedule 1.1;



 


		(b)	SELLERS will deliver to GHHC One Hundred Percent (100%) of the shares
(the “Vitana-X Interests”); and



 


SECTION 1.2 EFFECTIVE RESULT OF THE SHARE
EXCHANGE. At the Effective Date, Vitana-




    


     


    

X, will be acquired and will become a wholly-owned
subsidiary of GHHC.


 


SECTION 1.3 THE EXCHANGE OF CERTIFICATES.


 


		(a)	SELLERS will deliver all certificates representing all issued, cancelled,
and outstanding shares to GHHC., along with suitably executed stock powers, along with any other documents required for delivery
at the Closing by this Agreement.



 


		(b)	After the Closing, the Exchange Agent will be instructed to deliver
to the SELLERS their respective share certificates representing new shares of GHHC Series B Preferred Stock (each a “New
Certificate”).



 


SECTION 1.4 ACTS TO CARRY OUT THIS EXCHANGE
PLAN.


 


		(a)	Vitana-X and its proper officers and directors will do all such acts
and things as may be necessary or proper to vest, perfect, or confirm in GHHC title to such property or rights and otherwise to
carry out the purposes of this Share Exchange Agreement.



 


		(b)	If, at any time after the Effective Date, GHHC will consider or be
advised that any further assignments or assurances in law or any other acts are necessary or desirable to (i) vest, perfect, or
confirm, of record or otherwise, in GHHC its right, title, or interest in or under any of the rights, properties, or assets of
Vitana-X acquired or to be acquired by GHHC as a result of, or in connection with, the Share Exchange, or (ii) otherwise carry
out the purposes of this Agreement, Vitana-X and its proper officers and directors will be deemed to have granted to GHHC an irrevocable
power of attorney to execute and deliver all such proper deeds, assignments, and assurances in law and to do all acts necessary
or proper to vest, perfect, or confirm title to and possession of such rights, properties, or assets in GHHC and otherwise to carry
out the purposes of this Agreement; and the proper officers and directors of GHHC are fully authorized in the name of GHHC or otherwise
to take any and all such action.



 


SECTION 1.5 DIRECTORS AND EXECUTIVE OFFICERS.
Subject to the fiduciary duties of its directors, GHHC, as promptly as practicable after the Effective Date, will use its best
efforts to cause its existing board of directors and all officers to resign and immediately thereafter to be comprised of the directors
appointed by SELLERS.


 


SECTION 1.6 RESERVED.


 


SECTION 1.7 RESERVED.


 


ARTICLE II


 


EFFECTIVE DATE


 


The Effective Date shall be August 21, 2019.


 


ARTICLE III


 


CONDITIONS PRECEDENT TO PERFORMANCE OF
OBLIGATIONS OF THE PARTIES


 


The obligations of SELLERS and GHHC to consummate
the Share Exchange will be subject to the conditions that on or before the Effective Date:




    Page 2 of 18


     


    

 


SECTION 3.1 NOTICE TO SHAREHOLDERS OF GHHC.
The shareholders of GHHC will have been notified of the Agreement by filing a Form 8-K with the Securities and Exchange Commission.


 


SECTION 3.2 ABSENCE OF LEGAL PROCEEDINGS.
No action, suit, or proceeding will have been instituted or will have been threatened before any court or other governmental body
or by any public authority to restrain, enjoin, or prohibit the Share Exchange, or which would reasonably be expected to restrict
materially the operation of the business of Vitana-X or the exercise of any rights with respect thereto or to subject either of
the parties hereto or any of their subsidiaries, directors, or officers to any liability, fine, forfeiture, divestiture, or penalty
on the ground that the transactions contemplated hereby, the parties hereto, or their subsidiaries, directors, or officers have
breached or will breach any applicable law or regulation or have otherwise acted improperly in connection with the transactions
contemplated hereby and with respect to which the parties hereto have been advised by counsel that, in the opinion of such counsel,
such action, suit, or proceeding raises substantial questions of law or fact which could reasonably be decided materially adversely
to either party hereto or its subsidiaries, directors, or officers.


 


ARTICLE IV


 


CONDITIONS PRECEDENT TO PERFORMANCE OF
THE OBLIGATIONS OF GHHC


 


The obligations of GHHC are subject to the
satisfaction, on or prior to the Effective Date, of all the following conditions, compliance with which or the occurrence of which
may be waived in whole or in part by GHHC in writing unless not so permitted by law:


 


SECTION 4.1 REPRESENTATIONS AND WARRANTIES;
PERFORMANCE OF OBLIGATIONS. All representations and warranties of Vitana-X contained in this Agreement will be true and correct
in all material respects as of the Effective Date with the same effect as if such representations and warranties had been made
or given at and as of such date, except that representations and warranties of Vitana-X contained in this Agreement that specifically
relate to an earlier date will be true and correct in all material respects as of such earlier date. All covenants and obligations
to be performed or met by Vitana-X on or prior to the Effective Date will have been so performed or met. On the date of the Effective
Date, the chief executive officer of Vitana-X will deliver to GHHC a certificate to that effect. The delivery of such certificates
will in no way diminish the warranties, representations, covenants, and obligations of Vitana-X made in this Agreement.


 


SECTION 4.2 NO ADVERSE DEVELOPMENTS.


 


		(a)	During the period from June 30, 2019 to the Effective Date,
(i) there will not have been any material adverse effect as defined in section 12.5(c) (a “Material Adverse Effect”)
with respect to Vitana-X.



 


		(b)	As of the Effective Date, there will be no liabilities of Vitana-X,
other than liabilities incurred in the ordinary course of business, which are material to Vitana-X on a consolidated basis which
were not reflected in the Vitana-X Financial Statements, and there will be no material deterioration in the quality or market value
of the real property, investments and other assets included in such financial statements of Vitana-X.



 


SECTION 4.3 RESERVED.


 


ARTICLE V


 




    Page 3 of 18


     


    

CONDITIONS PRECEDENT TO PERFORMANCE OF
OBLIGATIONS OF SELLERS


 


The obligations of SELLERS hereunder are subject
to the satisfaction, on or prior to the Effective Date, of all the following conditions, compliance with which or the occurrence
of which may be waived in whole or in part by SELLERS in writing unless not so permitted by law:


 


SECTION 5.1 REPRESENTATIONS AND WARRANTIES;
PERFORMANCE OF OBLIGATIONS. All representations and warranties of GHHC contained in this Agreement will be true and correct
in all material respects as of the Effective Date with the same effect as if such representations and warranties had been made
or given at and as of such date, except that representations and warranties of GHHC contained in this Agreement that specifically
relate to an earlier date will be true and correct in all material respects as of such earlier date. All covenants and obligations
to be performed or met by GHHC on or prior to the Effective Date will have been so performed or met.


 


SECTION 5.2 NO ADVERSE DEVELOPMENTS.
During the period from June 30, 2019 to the Effective Date, there will not have been any Material Adverse Effect with respect
to GHHC, and SELLERS will have received a certificate dated the date of the Effective Date signed by either the president or an
executive vice president of GHHC to the foregoing effect. The delivery of such officer's certificate will in no way diminish the
warranties and representations of GHHC made in this Agreement.


 


ARTICLE VI


 


REPRESENTATIONS AND WARRANTIES OF PUBLIC
COMPANY


 


GHHC represents and warrants to SELLERS as
follows:


 


SECTION 6.1 ORGANIZATION, POWERS, AND QUALIFICATION.
GHHC is a duly organized, validly existing corporation in good standing under the laws of its jurisdiction of incorporation and
has all requisite corporate power and authority to own and operate its properties and assets, to lease its properties and to carry
on its business as now conducted. GHHC owns or possesses in the operation of its business all franchises, licenses, permits, certificates,
consents, approvals, waivers, and other authorizations, governmental or otherwise, which are necessary for it to conduct its business
as now conducted.


 


SECTION 6.2 EXECUTION AND PERFORMANCE OF
AGREEMENT. GHHC has all requisite corporate power and authority to execute and deliver this Agreement and to perform its respective
terms.


 


SECTION 6.3 BINDING OBLIGATIONS, DUE AUTHORIZATION.
Subject to the approval of its shareholders, this Agreement constitutes a valid, legal, and binding obligation of GHHC, enforceable
against it in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, or similar
law, or by general principles of equity. The execution, delivery, and performance of this Agreement and the transactions contemplated
thereby have been duly and validly authorized by the board of directors of GHHC.


 


SECTION 6.4 ABSENCE OF VIOLATIONS. GHHC
is not (i) in violation of its bylaws, (ii) in violation of any applicable federal, state, or local law or ordinance or any order,
rule, or regulation of any federal, state, local, or other governmental agency or body, (iii) in violation of or in default with
respect to any order, writ, injunction, or decree of any court, or any order, license, regulation, or demand of any governmental
agency; (iv) in violation of any term of any security agreement, mortgage, indenture, or any other contract, agreement, instrument,
lease, or certificate, and GHHC has not received any claim or notice of violation.


 




    Page 4 of 18


     


    

SECTION 6.5 ABSENCE OF DEFAULT. None
of the execution or the delivery of this Agreement, the consummation of the transactions contemplated hereby, or the compliance
with or fulfillment of the terms hereof will conflict with, or result in a breach of any of the terms, conditions, or provisions
of, or constitute a default under the organizational documents or bylaws of GHHC. None of such execution, consummation, or fulfillment
will (a) conflict with, or result in a material breach of the terms, conditions, or provisions of, or constitute a material violation,
conflict, or default under, or give rise to any right of termination, cancellation, or acceleration with respect to, or result
in the creation of any lien, charge, or encumbrance upon, any of the property or assets of GHHC pursuant to any material agreement
or instrument under which it is obligated or by which any of its properties or assets may be bound, including without limitation
any material lease, contract, mortgage, promissory note, loan, credit arrangement or other commitment or arrangement of it in respect
of which it is an obligor.


 


SECTION 6.6 SUBSIDIARIES. GHHC does
not have any direct or indirect subsidiaries and does not directly or indirectly own, control, or hold, with the power to vote,
any shares of the capital stock of any entity (including, without limitation, corporations, partnerships, and joint ventures).
There are no outstanding subscriptions, options, warrants, convertible securities, calls, commitments, or agreements calling for
or requiring the issuance, transfer, sale, or other disposition of any shares of the capital stock of GHHC. There are no other
direct or indirect subsidiaries of GHHC that would be or are required to be consolidated or accounted for on the equity method
in the consolidated financial statements of GHHC prepared in accordance with generally accepted accounting principles.


 


SECTION 6.7 CAPITAL STRUCTURE.


 


		(a)	The authorized capital stock of GHHC consists of 5,000,000,000 shares
of GHHC Common Stock having no par value per share, of which, as of the date of this Agreement, 339,573,445 shares are issued and
outstanding. GHHC additionally has 10,000,000 Preferred Shares authorized, of which 1,000,000 have been designated as Series A
Preferred Stock and 1,000,000 have been designated as Series B Preferred Stock. The shares of GHHC Series A Preferred, in total,
consist of exactly 65% of all voting rights available at the time of any vote, including Series A Preferred Stock. Series B Preferred
Stockholders have no voting rights. Common Stock are entitled to one vote per share held; and there are no outstanding subscriptions,
options, warrants, convertible securities, calls, commitments, agreements or rights, including preemptive rights, calling for or
requiring the issuance, transfer, sale, or other disposition of any shares of the capital stock of GHHC except those listed on
Schedule 6.7. No shares of GHHC Common Stock are held as treasury shares. None of the GHHC Common Stock is subject to any restrictions
upon the transfer thereof under the terms of the articles of incorporation or bylaws of GHHC.



 


		(b)	As of the date hereof, to the best of the knowledge of GHHC, and
except for this Agreement, there are no shareholder agreements, or other agreements, understandings, or commitments relating to
the right of any holder or beneficial owner of any issued and outstanding shares of GHHC Common Stock to vote or to dispose of
his, her or its shares of GHHC Common Stock.



 


SECTION 6.8 ARTICLES OF INCORPORATION, BYLAWS,
AND MINUTE BOOKS. GHHC has provided Vitana-X with all known, true, correct and complete copies of all of the certificates or
articles of incorporation and all amendments to it, and the bylaws, as amended, of GHHC. All minute books contain accurate minutes
of all meetings and accurate consents in lieu of meetings of the board of directors (and any board committee) and of the shareholders
of GHHC since inception. All minute books accurately reflect all transactions referred to in such minutes and consents in lieu
of meetings and disclose all material corporate actions of the shareholders and boards of directors of GHHC and all committees
thereof. Except as reflected in such minute books, there are no minutes of meetings or consents in lieu of meetings of the board
of directors (or board any committee) or of shareholders of GHHC known to the Board of Directors




    Page 5 of 18


     


    

that have not been disclosed to SELLERS.


 


SECTION 6.9 BOOKS AND RECORDS. The books
and records of GHHC fairly reflect the transactions to which it is a party or by which its properties are subject or bound. To
the Board of Directors’ best knowledge, such books and records have been properly kept and maintained and are in compliance
in all material respects with all applicable accounting and legal requirements.


 


SECTION 6.10 CONTRACTS, COMMITMENTS, ETC.
If there are any, GHHC has made available to Vitana-X:


 


		(a)	All contracts, agreements, plans or other arrangements applicable
to employees, officers, or directors of GHHC, including compensation, bonus, stock option, stock purchase, medical, disability,
group life or other insurance plans, and any other remuneration or fringe benefit arrangements.



 


		(b)	All material contracts, agreements, leases, mortgages, and commitments
to which GHHC is a party or may be bound; or, if any of the same be oral, true, accurate, and complete written summaries of all
such oral contracts, agreements, leases, mortgages, and commitments.



 


		(c)	All contracts, agreements, leases, mortgages, and commitments, whether
or not material, to which GHHC is a party or may be bound and which require the consent or approval of third parties to the execution
and delivery of this Agreement or to the consummation or performance of any of the transactions contemplated thereby or, if any
of the same be oral, true, accurate, and complete written summaries of all such oral contracts, agreements, leases, mortgages,
and commitments.



 


		(d)	All deeds, leases, contracts, agreements, mortgages, and commitments,
whether or not material, to which GHHC is a party or may be bound and which relate to land, buildings, fixtures, or other real
property.



 


		(e)	All federal, state, and local tax returns, including any amended
returns, filed by GHHC.



 


SECTION 6.11 MATERIAL CONTRACT DEFAULTS.
All contracts, agreements, leases, mortgages, or commitments referred to above in section 6.10 are valid and in full force and
effect on this date. As of the date of this Agreement and as of the Effective Date, neither GHHC nor its subsidiaries will be in
default in any material respect under any material contract, commitment, arrangement, lease, insurance policy, or other instrument
to which it is a party or by which its assets, business, or operations may be bound or affected or under which it or its assets,
business, or operations receive benefits; and there has not occurred any event that with the lapse of time or the giving of notice
or both would constitute such a default.


 


ARTICLE VII


 


COVENANTS OF GHHC


 


GHHC covenants and agrees as follows:


 


SECTION 7.1 RIGHTS OF ACCESS. From this
date to the Effective Date, GHHC will give to SELLERS and to their respective representatives, including its certified public accountants
full access during normal business hours to all of the property, documents, contracts, books, and records of GHHC, and such information
with respect to its business affairs and properties as Vitana-X from time to time may reasonably request.


 




    Page 6 of 18


     


    

SECTION 7.2 EXTRAORDINARY TRANSACTIONS.
Without the prior written consent of SELLERS, GHHC will not, on or after the date of this Agreement: (a) declare or pay any cash
dividends or property dividends with respect to any class of its capital stock; (b) declare or distribute any stock dividend, authorize
a stock split, or authorize, issue or make any distribution of its capital stock or any other securities or grant any options to
acquire such additional securities; (c) either (i) merge into, consolidate with, or sell or otherwise dispose of its assets to
any other corporation or person, or enter into any other transaction or agree to effect any other transaction not in the ordinary
course of its business except as explicitly contemplated herein, or (ii) engage in any discussions concerning such a possible transaction
except as explicitly contemplated herein unless the board of directors of GHHC, based upon the advice of legal counsel, determines
in good faith that such action is required for the board of directors to comply with its fiduciary duties to stockholders imposed
by law; (d) convert the form of entity of GHHC from that in existence on the date of this Agreement to any other form of entity;
(e) make any direct or indirect redemption, purchase, or other acquisition of any of its capital stock; (f) except in the ordinary
course of its business or to accomplish the transactions contemplated by this Agreement, incur any liability or obligation, make
any commitment or disbursement, acquire or dispose of any property or asset, make any contract or agreement, pay or become obligated
to pay any legal, accounting, or miscellaneous other expense, or engage in any transaction; (g) other than in the ordinary course
of business, subject any of its properties or assets to any lien, claim, charge, option, or encumbrance; (h) enter into or assume
any one or more commitments to make capital expenditures, any of which individually exceeds $20,000 or which in the aggregate exceed
$50,000; (i) except for increases in the ordinary course of business in accordance with past practices, and except as explicitly
contemplated by this Agreement, increase the rate of compensation of any employee or enter into any agreement to increase the rate
of compensation of any employee; (j) except as otherwise required by law, create or modify any profit sharing plan, bonus, deferred
compensation, death benefit, or retirement plan, or the level of benefits under any such plan, nor increase or decrease any severance
or termination pay benefit or any other fringe benefit; (k) enter into any employment or personal services contract with any person
or firm, except directly to facilitate the transactions contemplated by this Agreement; nor (l) change the nature or increase the
concentration of risk of investments and of cash and cash equivalents.


 


SECTION 7.3 PRESERVATION OF BUSINESS.
GHHC will (a) carry on its business and manage its assets and properties diligently and substantially in the same manner as heretofore;
(b) use commercially reasonable efforts to continue in effect its present insurance coverage on all properties, assets, business,
and personnel; (c) use commercially reasonable efforts to preserve its business organization intact, to keep available its present
employees, and to preserve its present relationships with all those entities having business dealings with it; (d) not do anything
and not fail to do anything which will cause a breach of or default in any contract, agreement, commitment, or obligation to which
it is a party or by which it may be bound; and (e) conduct its affairs so that at the Effective Date none of its representations
and warranties will be inaccurate, none of its covenants and agreements will be breached, and no condition in this Agreement will
remain unfulfilled by reason of its actions or omissions.


 


SECTION 7.4 AFFILIATES. GHHC will furnish
to SELLERS a list of all persons known to GHHC who at the date of this Agreement may be deemed to be “affiliates” of
GHHC within the meaning of Rule 145 under the Securities Act of 1933.


 


SECTION 7.5 PURCHASE METHOD TREATMENT.
GHHC will take no action that would prevent or impede the Share Exchange from qualifying as a reverse acquisition under the purchase
method for business combinations.


 


SECTION 7.6 UPDATED SCHEDULES. Not less
than fifteen business days prior to the Effective Date and as of the Effective Date, GHHC will deliver to SELLERS any updates to
the schedules to its representations which may be required to disclose events or circumstances arising after this date. Such




    Page 7 of 18


     


    

schedules will be updated only for the purpose of making
the representations and warranties contained in this Agreement to which such part of such schedules relate true and correct in
all material respects as of the date such schedule is updated, and the updated schedule will not have the effect of making any
representation or warranty contained in this Agreement true and correct in all material respects as of a date prior to the date
of such updated schedule. For purposes of determining whether the conditions set forth in section 4.1 to SELLERS’ obligations
have been met, any such updated schedules delivered to SELLERS will be disregarded unless SELLERS will have agreed to accept any
changes reflected in such updated schedules.


 


SECTION 7.7 SUBSEQUENT EVENTS. Until
the Effective Date, GHHC will immediately advise SELLERS in a detailed written notice of any fact or occurrence or any pending
or threatened occurrence of which it obtains knowledge and which (if existing and known at the date of the execution of this Agreement)
would have been required to be set forth or disclosed in or pursuant to this Agreement or which (if existing and known at any time
prior to or at the Effective Date) would cause a condition to SELLERS’s obligations under this Agreement not to be fully
satisfied.


 


ARTICLE VIII


 


REPRESENTATIONS AND WARRANTIES OF VITANA-X


 


Vitana-X, by and through SELLERS, represents
and warrants to GHHC as follows:


 


SECTION 8.1 ORGANIZATION, POWERS, AND QUALIFICATION.
Vitana-X is a duly organized, validly existing limited liability company in good standing under the laws of its jurisdiction of
incorporation and has all requisite corporate power and authority to own and operate its property and assets, to lease properties
used in its business, and to carry on its business as now conducted. Vitana-X owns or possesses in the operation of its business
all franchises, licenses, permits, certificates, consents, approvals, waivers, and other authorizations, governmental or otherwise,
which are necessary for it to conduct its business as now conducted.


 


SECTION 8.2 EXECUTION AND PERFORMANCE OF
AGREEMENT. Vitana-X has all requisite corporate power and authority to execute and deliver this Agreement and to perform its
respective terms.


 


SECTION 8.3 BINDING OBLIGATIONS, DUE AUTHORIZATION.
Subject to the approval of its shareholders, this Agreement constitutes a valid, legal, and binding obligation of Vitana-X, enforceable
against it in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, or similar
law, or by general principles of equity. The board of directors of Vitana-X has validly authorized the execution, delivery, and
performance of this Agreement and the transactions contemplated by it.


 


SECTION 8.4 ABSENCE OF DEFAULT. None
of the execution or the delivery of this Agreement, the consummation of the transactions contemplated by it, or the compliance
with or fulfillment of its terms will conflict with, or result in a breach of any of the terms, conditions, or provisions of, or
constitute a default under the organizational documents or bylaws of Vitana-X. None of such execution, consummation, or fulfillment
will conflict with, or result in a material breach of the terms, conditions, or provisions of, or constitute a material violation,
conflict, or default under, or give rise to any right of termination, cancellation, or acceleration with respect to, or result
in the creation of any lien, charge, or encumbrance upon, any of the property or assets of Vitana-X pursuant to any material agreement
or instrument under which it is obligated or by which any of its properties or assets may be bound, including without limitation
any material lease, contract, mortgage, promissory note, deed of trust, loan, credit arrangement, or other commitment or arrangement
of it in respect of which it is an obligor.




    Page 8 of 18


     


    

 


SECTION 8.5 CAPITAL STRUCTURE.


 


		(a)	The shares of Vitana-X as of the date of this Agreement consists
of 74 shareholders of Vitana-X holding exactly 68,515,124 shares of Common Stock as per described in Schedule 1.1 attached hereto
and have been duly issued and are validly outstanding, fully paid and non-assessable, book entry the shares. These shares of Vitana-X
are the only equity securities of Vitana-X authorized, issued, or outstanding as of the date of this Agreement. There are no outstanding
subscriptions, options, warrants, convertible securities, calls, commitments, agreements or rights, including preemptive rights,
calling for or requiring the issuance, transfer, sale, or other disposition of any shares of the capital stock of Vitana-X.



 


		(b)	As of the date hereof, to the best of the knowledge of Vitana-X,
and except for this Agreement, there are no shareholder agreements, or other agreements, understandings, or commitments relating
to the right of any holder or beneficial owner of any issued and outstanding shares of Vitana-X Common Stock to vote or to dispose
of his, her or its shares of Vitana-X Common Stock.



 


SECTION 8.6 BOOKS AND RECORDS. The books
and records of Vitana-X fairly reflect the transactions to which it is a party or by which its properties are subject or bound.
Such books and records have been properly kept and maintained and are in compliance in all material respects with all applicable
accounting and legal requirements. Vitana-X follows generally accepted accounting principles applied on a consistent basis in the
preparation and maintenance of its books of account and financial statements, including using the accrual method of accounting
for all items of income and expense. Vitana-X has made all accruals in amounts that accurately report income and expense in the
proper periods in accordance with generally accepted accounting principles. Vitana-X has filed all material reports and returns
required by any law or regulation to be filed by it.


 


SECTION 8.7 FINANCIAL STATEMENTS. Vitana-X
has furnished to GHHC its balance sheet from inception through December 31, 2018, and its related statements of operations, changes
in stockholders' equity and cash flows for the periods then ended, and its notes, and its consolidated unaudited balance sheet
as of December 31, 2018 and its related unaudited consolidated statements of operations, changes in stockholders' equity
and cash flows for the nine month period then ended (the “Vitana-X Interim Financial Statements”) (collectively, the
“Vitana-X Financial Statements”). All of the Vitana-X Financial Statements, including the related notes, (a) were prepared
in accordance with generally accepted accounting principles (“GAAP”) consistently applied in all material respects
(subject, in the case of the Vitana- Interim Financial Statements, to recurring audit adjustments normal in nature and amount),
(b) are in accordance with the books and records of Vitana-X, (c) fairly reflect the consolidated financial position of Vitana-X
as of such dates, and the consolidated results of operations of Vitana-X for the periods ended on such dates, and do not fail to
disclose any material extraordinary or out-of- period items. Vitana-X represents and warrants that its financial statements are
prepared sufficiently to enable a PCAOB listed audit firm to prepare and express an opinion thereon and to agree with Vitana-X
that its financial statements are prepared according to GAAP and appear to be free from material misstatement.


 


SECTION 8.8 ARTICLES OF ORGANIZATION, OPERATING
AGREEMENT, AND MINUTE BOOKS. Vitana-X has provided GHHC with true, correct and complete copies of all of Vitana-X’s articles
of organization, the operating agreement, and all amendments to such documents, and the minute books. All minute books contain
accurate minutes of all meetings and accurate consents in lieu of meetings of the board of directors (and any board committee)
and of the shareholders of Vitana-X since its inception. All minute books accurately reflect all transactions referred to in such
minutes and consents in lieu of meetings and disclose all material corporate actions of the shareholders and boards of directors
of Vitana-X and all board committees. Except as reflected in such minute books, there are no minutes of meetings or consents




    Page 9 of 18


     


    

in lieu of meetings of the board of directors (or any
committee thereof) or of shareholders of Vitana-X.


 


SECTION 8.9 ABSENCE OF CERTAIN DEVELOPMENTS.
Since December 31, 2018, there has been (a) no Material Adverse Effect with respect to Vitana-X, (b) no material decrease in the
value of the assets of Vitana-X (c) no material increase in the level of liabilities of Vitana-X. Since December 31, 2018, Vitana-X
has conducted its business only in the ordinary course of such business and consistent with past practice.


 


SECTION 8.10 DISCLOSURE. No representation
or warranty included in this and no certificate, statement, or other document delivered by Vitana-X hereunder or in connection
with this Agreement or any of the transactions contemplated thereunder contains any untrue statement of a material fact or omits
to state a material fact necessary in order to make the statements contained herein, in light of the circumstances under which
they were made, not misleading. There is no fact known to Vitana-X that might materially adversely affect its business, assets,
liabilities, financial condition, results of operations, or prospects that has not been disclosed in the Vitana-X Financial Statements
or a certificate, schedule or other document delivered by Vitana-X to GHHC. Copies of all documents delivered to GHHC by Vitana-X
under this Agreement are true, correct, and complete copies thereof and include all amendments, supplements, and modifications
thereto and all waivers thereunder.


 


ARTICLE IX


 


COVENANTS OF VITANA-X


 


Vitana-X, by and through its President and
Board of Directors, covenant and agree as follows:


 


SECTION 9.1 RIGHTS OF ACCESS. From this
date to the Effective Date, Vitana-X will give to GHHC and to its representatives, including their certified public accountants,
reasonable access during normal business hours upon reasonable advance notice to all of the property, documents, contracts, books,
and records of Vitana-X, and such information with respect to its business affairs and properties as Vitana-X from time to time
may reasonably request, and GHHC will be furnished with copies of all such books, records, agreements and other documents as may
be reasonably requested by it. In connection with such investigation, GHHC will also be permitted to speak with such officers,
directors, bankers, creditors, lessees, lessors, customers, shareholders, and litigation counsel of Vitana-X as GHHC may specify.


 


SECTION 9.2 EXTRAORDINARY TRANSACTIONS.
Without the prior written consent of GHHC, Vitana-X will not, on or after the date of this Agreement: (a) declare or pay any cash
dividends or property dividends with respect to any class of its capital stock; (b) declare or distribute any stock dividend nor
authorize a stock split; (c) merge into, consolidate with, or sell or otherwise dispose of its assets to any other corporation
or person, or enter into any other transaction or agree to effect any other transaction not in the ordinary course of its business
except as explicitly contemplated herein; (d) convert the form of entity of Vitana-X from that in existence on the date of this
Agreement to any other form of entity; (e) make any direct or indirect redemption, purchase, or other acquisition of any of its
capital stock; (f) except in the ordinary course of its business or to accomplish the transactions contemplated by this Agreement,
incur any liability or obligation, make any commitment or disbursement, acquire or dispose of any property or asset, make any contract
or agreement, pay or become obligated to pay any legal, accounting, or miscellaneous other expense, or engage in any transaction;
(g) other than in the ordinary course of business, subject any of its properties or assets to any lien, claim, charge, option,
or encumbrance; (h) enter into or assume any one or more commitments to make capital expenditures, any of which individually exceeds
$20,000 or which in the aggregate exceed $50,000; (i) except for increases in the ordinary course of business in accordance with
past practices and except as explicitly contemplated by this Agreement, increase the rate of compensation of any employee or enter
into any agreement to increase the rate of compensation of any employee; (j) except as otherwise required by law, create or modify
any pension or profit sharing plan,




    Page 10 of 18


     


    

bonus, deferred compensation, death benefit, or retirement
plan, or the level of benefits under any such plan, nor increase or decrease any severance or termination pay benefit or any other
fringe benefit; (k) enter into any employment or personal services contract with any person or firm, except directly to facilitate
the transactions contemplated by this Agreement; nor (l) change the nature or increase the concentration of risk of cash and cash
equivalents.


 


SECTION 9.3 PRESERVATION OF BUSINESS.
Vitana-X will: (a) carry on its business and manage its assets and property diligently and substantially in the same manner as
was done previously; (b) use commercially reasonable efforts to continue in effect its present insurance coverage on all property,
assets, business, and personnel; (c) use commercially reasonable efforts to preserve its business organization intact, to keep
available its present employees, and to preserve its present relationships with those entities having business dealings with it;
(d) not do anything and not fail to do anything which will cause a breach of or default in any contract, agreement, commitment,
or obligation to which it is a party or by which it may be bound; and (e) conduct its affairs so that at the Effective Date none
of its representations and warranties will be inaccurate, none of its covenants and agreements will be breached, and no condition
in this Agreement will remain unfulfilled by reason of its actions or omissions.


 


SECTION 9.4 SHAREHOLDERS' MEETING. Unless
a majority of shareholders will provide their written consent, Vitana-X will hold a meeting of its shareholders in accordance with
the laws of the state of Florida and the operating agreement of Vitana-X to consider and vote upon this Agreement. Subject to its
fiduciary duty to shareholders, the managers of Vitana-X will recommend to its shareholders that this Agreement be adopted.


 


SECTION 9.5. SUBSEQUENT EVENTS. Until
the Effective Date, Vitana-X will immediately advise GHHC in a detailed written notice of any fact or occurrence or any pending
or threatened occurrence of which it obtains knowledge and which (if existing and known at the date of the execution of this Agreement)
would have been required to be set forth or disclosed in or pursuant to this Agreement or which (if existing and known at the time
of the Effective Date) would cause a condition to GHHC’s obligations under this Agreement not to be fully satisfied.


 


SECTION 9.6 UPDATED SCHEDULES. Not less
than fifteen business days prior to the Effective Date and as of the Effective Date, Vitana-X will deliver to GHHC any updates
to the schedules to its representations which may be required to disclose events or circumstances arising after the date hereof.
Such schedules will be updated only for the purpose of making the representations and warranties contained in this Agreement to
which such part of such schedules relate true and correct in all material respects as of the date such schedule is updated, and
the updated schedule will not have the effect of making any representation or warranty contained in this Agreement true and correct
in all material respects as of a date prior to the date of such updated schedule. For purposes of determining whether the conditions
set forth in section 4.1 to Vitana-X’s obligations have been met, any such updated schedules delivered to GHHC will be disregarded
unless GHHC will have agreed to accept any changes reflected in such updated schedules.


 


SECTION 9.7 RESERVED.


 


SECTION X


 


CLOSING


 


SECTION 10.1 PLACE AND TIME OF CLOSING.
Closing will take place at such place as the parties choose, on the date of the Effective Date, provided that all conditions precedent
to the obligations of the parties to close have then been met or waived.


 




    Page 11 of 18


     


    

SECTION XI


 


TERMINATION, WAIVER, AND AMENDMENT


 


SECTION 11.1 TERMINATION BY REASON OF LAPSE
OF TIME. This Agreement may be terminated by any party after December 31, 2019, by instrument duly authorized and executed
and delivered to the other party, unless the Effective Date will have occurred.


 


SECTION 11.2 GROUNDS FOR TERMINATION.
This Agreement may be terminated by written notice of termination at any time before the Effective Date (whether before or after
action by stockholders of GHHC or Vitana-X):


 


		(a)	by mutual consent of the parties hereto;



 


		(b)	by SELLERS, upon written notice to GHHC given at any time (i) if
any of the representations and warranties of GHHC contained in Article VI above was materially incorrect when made, or (ii) in
the event of a material breach or material failure by GHHC of any covenant or agreement of GHHC contained in this Agreement that
has not been, or cannot be, cured within thirty days after written notice of such breach or failure is given to GHHC, and which
inaccuracy, breach, or failure, if continued to the Effective Date, would result in any condition set forth in Article IV above
not being satisfied;



 


		(c)	by GHHC, upon written notice to SELLERS given at any time (i) if
any of the representations, warranties, or covenants of SELLERS contained in Articles VIII or IX above was materially incorrect
when made, or (ii) in the event of a material breach or material failure by SELLERS of any covenant or agreement of SELLERS contained
in this Agreement that has not been, or cannot be, cured within thirty days after written notice of such breach or failure is given
to SELLERS, and which inaccuracy, breach, or failure, if continued to the Effective Date, would result in any condition set forth
in Article V above not being satisfied; and



 


		(d)	by either SELLERS or GHHC upon written notice given to the other
if the shareholders of either Vitana-X or GHHC will have voted on and failed to adopt this Agreement, at the meeting of such shareholders
called for such purpose.



 


SECTION 11.3 EFFECT OF TERMINATION.
In the event of the termination and abandonment of this Agreement pursuant to the provisions of section 11.1 or section 11.2, this
Agreement will become void and have no force or effect without any liability on the part of Vitana-X, GHHC, or their respective
directors or officers or shareholders, in respect of this Agreement. Notwithstanding the foregoing, as provided in section 12.4
of this Agreement, the confidentiality agreement contained in that section will survive such termination.


 


SECTION 11.4 WAIVER OF TERMS OR CONDITIONS.
Any of the terms or conditions of this Agreement, to the extent legally permitted, may be waived at any time prior to the Effective
Date by the party which is, or whose shareholders are, entitled to the benefit thereof, by action taken by that party, by the board
of directors of such party, or by its chairman, or by its president; provided that such waiver will be in writing and will be taken
only if, in the judgment of the party, board of directors, or officer taking such action, such waiver will not have a materially
adverse effect on the benefits intended hereunder to it or to the shareholders of its or his corporation; and the other parties
hereto may rely on the delivery of such a waiver as conclusive evidence of such judgment and the validity of the waiver.


 


SECTION 11.5 AMENDMENT. Anything herein
or elsewhere to the contrary notwithstanding, to the




    Page 12 of 18


     


    

extent permitted by law, this Agreement and the exhibits
hereto may be amended, supplemented, or interpreted at any time prior to the Effective Date by written instrument only duly authorized
and executed by each of the parties hereto; provided, however, that (except as specifically provided herein or as may be approved
by such shareholders) this Agreement may not be amended after:


 


		(a)	the action by shareholders of GHHC in any respect that would change
(i) the amount or kind of shares, obligations, cash, property, or rights to be received in exchange for or on conversion of the
GHHC Series B Preferred Stock; (ii) any term of the certificate of incorporation of Vitana-X to be effected by the Share Exchange;
or (iii) any of the terms and conditions of this Agreement if the change would adversely affect the shareholders of GHHC, or



 


		(b)	the action by shareholders of Vitana-X in any respect that would
change (i) the amount or kind of shares, obligations, cash, property, or rights to be received in exchange for the Vitana-X Common
Stock to be delivered in the Share Exchange; (ii) any term of the certificate of incorporation of Vitana-X to be effected by the
Share Exchange; or (iii) any of the terms and conditions of this Agreement if the change would adversely affect the shareholders
of Vitana-X.



 


ARTICLE XII


 


GENERAL PROVISIONS


 


SECTION 12.1 ALLOCATION OF COSTS AND EXPENSES.
Except as provided in Article IX, each party will pay its own fees and expenses, including without limitation the fees and expenses
of its own counsel and its own accountants and tax advisers, incurred in connection with this Agreement and the transactions contemplated
by it.


 


SECTION 12.2 MUTUAL COOPERATION. Subject
to the terms and conditions herein provided, each party will use its best efforts, and will cooperate fully with the other party,
in expeditiously carrying out the provisions of this Agreement and in expeditiously making all filings and obtaining all necessary
approvals, and as soon as practicable will execute and deliver, or cause to be executed and delivered, such notifications and additional
documents and instruments and do or cause to be done all additional things necessary, proper, or advisable under applicable law
to consummate and make effective on the earliest practicable date the transactions contemplated hereby.


 


SECTION 12.3 FORM OF PUBLIC DISCLOSURES.
Vitana-X and GHHC will mutually agree in advance upon the form and substance of all public disclosures concerning this Agreement
and the transactions contemplated by it and will not issue any such public disclosure prior to such consultation, except that GHHC
in its sole discretion will determine the content of all SEC filings required to be filed through the Effective Date. As for all
other disclosures, approval by Vitana-X or GHHC of such public disclosure will not be unreasonably withheld.


 


SECTION 12.4 CONFIDENTIALITY. SELLERS
and GHHC will use all information that each obtains from the other pursuant to this Agreement solely for the effectuation of the
transactions contemplated by this Agreement or for other purposes consistent with the intent of this Agreement. Neither SELLERS
nor GHHC will use any of such information for any other purpose, including, without limitation, the competitive detriment of any
other party. SELLERS and GHHC will maintain as strictly confidential all information each of them learns from the other and will,
at any time after termination of this Agreement in accordance with its terms, upon the request of the other, return promptly to
it all documentation provided by it or made available to third parties. Each of the parties may disclose such information to its
respective affiliates, counsel, accountants, tax advisers, and consultants, provided that such parties are advised of the confidential
nature of such information and agree to be bound by the terms of this section 12.4. The




    Page 13 of 18


     


    

confidentiality agreement contained in this section
12.4 will remain operative and in full force and effect and will survive the termination of this Agreement.


 


SECTION 12.5 STANDARD OF MATERIALITY AND
OF MATERIAL ADVERSE EFFECT


 


		(a)	For purposes of Articles IV, VI, and VII of this Agreement, the terms
“material” and “materially,” when used with reference to items normally expressed in dollars, will be deemed
to refer to amounts individually and in the aggregate in excess of 3% of the shareholders' equity of GHHC as of June 8,
as determined in accordance with generally accepted accounting principles.



 


		(b)	For purposes of Articles V, VIII, and IX of this Agreement, the terms
“material” and “materially,” when used with reference to items normally expressed in dollars, will be deemed
to refer to amounts individually and in the aggregate in excess of 3% of the shareholders’ equity of Vitana-X as of December
31, 2018, as determined in accordance with generally accepted accounting principles.



 


		(c)	The term “Material Adverse Effect” wherever used in this
Agreement will mean, with respect to a party, a material adverse effect on the business, results of operations, financial condition,
including the market value of any of the assets, or prospects of such party and its subsidiaries taken as a whole.



 


SECTION 12.6 COUNTERPARTS. This Agreement
may be executed in two or more counterparts each of which will be deemed to constitute an original, but such counterparts together
will be deemed to be one and the same instrument and to become effective when one or more counterparts have been signed by each
of the parties. It will not be necessary in making proof of this Agreement or any counterpart hereof to produce or account for
the other counterpart.


 


SECTION 12.7 ENTIRE AGREEMENT. This
Agreement sets forth the entire understanding of the parties hereto with respect to their commitments to each other and their undertakings
vis-à-vis each other on the subject matter hereof. Any previous agreements or understandings among the parties regarding
the subject matter hereof are merged into and superseded by this Agreement. Nothing in this Agreement express or implied is intended
or will be construed to confer upon or to give any person, other than Vitana-X, GHHC, and their respective shareholders, any rights
or remedies under or by reason of this Agreement.


 


SECTION 12.8. SURVIVAL OF REPRESENTATIONS,
WARRANTIES, AND COVENANTS. None of the representations, warranties, covenants, and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement, will survive the Effective Date, except for sections 12.4 and 12.6, and those other covenants
and agreements contained herein and therein which by their terms apply in whole or in part after the Effective Date.


 


SECTION 12.9 SECTION HEADINGS. This
Agreement's section and subsection headings in have been inserted for convenience of reference only and will in no way modify or
restrict any of the terms or provisions.


 


SECTION 12.10 NOTICES.


 


		(a)	All notices, consents, waivers, or other communications which are
required or permitted hereunder will be in writing and deemed to have been duly given if delivered personally or by messenger,
sent by facsimile, or by registered or certified mail, return receipt requested, postage prepaid, or by a reputable delivery service
(including, by way of example and not limitation, Federal Express, UPS and DHL) which makes a record of the date and time of delivery.
All communications will be addressed to the appropriate address of each party as follows:





    Page 14 of 18


     


    

 


If to SELLERS:


c/o Vitana-X, Inc.


P.O. Box 310367 PMB 11660


Miami, FL 33231


 


If to GHHC:


GH Capital, Inc.


200 South Biscayne Blvd.,


Suite 2790


Miami, FL 33131


 


With copy to:


Eilers Law Group, P.A.


Attention: William Eilers


149 S. Lexington Ave.


Asheville, NC 28801


 


		(b)	For purposes of notice, the address of each Party will be the address
first set forth above; provided, however, that each Party will have the right to change its respective address for notices hereunder
to another location by giving ten days advance written notice to the other Party in the manner set forth above.



 


		(c)	All such notices will be deemed to have been given on the date delivered,
transmitted, or mailed in the manner provided above.



 


SECTION 12.11 CHOICE OF LAW. This Agreement
will be governed by, construed, and enforced in accordance with the laws of the State of Florida, without giving effect to the
principles of conflict of law thereof. Each of the parties agrees that it may be served with process in any action with respect
to this Agreement or the transactions contemplated by it by certified or registered mail, return receipt requested, or to its registered
agent for service of process in the State of Florida, respectively.


 


SECTION 12.12 KNOWLEDGE OF A PERSON.
References in this Agreement to the knowledge of a party will mean, in the case of a corporation, the actual knowledge possessed
by the present executive officers of such party.


 


SECTION 12.13 BINDING AGREEMENT. This
Agreement will be binding upon the parties and their respective heirs, successors and assigns.


 


 


 


 


SPACE LEFT INTENTIONALLY BLANK. SIGNATURES
TO FOLLOW.


 


 


 


 


 


 


 


 




    Page 15 of 18


     


    

 


 


THE PARTIES, INTENDING TO BE LEGALLY BOUND,
have executed this agreement on the date first set forth above.


 


	
        “GH CAPITAL, INC.”

         
	“VITANA-X, INC.”
	
        GH Capital Inc.

        a Florida corporation

        By: /s/Wolfgang Ruecker_______________

        Name: Wolfgang Ruecker

        Title: Director

         
	
        Vitana-X, Inc.,

        a Florida corporation

        By: /s/Dirk Richter____________

        Name: Dirk Richter

        Title: Director

         





    Page 16 of 18


     


    

 


SCHEDULE 1.1


VITANA-X SHAREHOLDERS


 


	Shareholder Name	# Shares	% owned	# Shares Series B
	1185880 B.C. LTD	2,500,000	3.649%	36,488
	Paul Abraham	28,037	0.041%	409
	Gina Angel	94,073	0.137%	1,373
	Josef El Assal	35,098	0.051%	512
	Wolfgang Bartsch	140,087	0.204%	2,045
	Daniel Bichler	13,925	0.020%	203
	Franz Bonner	6,666,667	9.730%	97,302
	Diana Brandt	42,238	0.062%	616
	Central Park Investments LLP	3,000,000	4.379%	43,786
	Michael Decker	42,399	0.062%	619
	Nenad Dimic	500,000	0.730%	7,298
	Goran Djuricin	98,129	0.143%	1,432
	Marco Djuricin	70,025	0.102%	1,022
	Jacobus Willem Johannes Van Der Eijk	558,975	0.816%	8,158
	Manfred Feiertag	67,190	0.098%	981
	Matthias Goeth	2,000,000	2.919%	29,191
	Christoph Goth	154,500	0.225%	2,255
	Elisabeth Grotzl	35,211	0.051%	514
	Lukas Grotzl	13,704	0.020%	200
	Karl Heinz Jamnig	111,976	0.163%	1,634
	Markus Hell	11,200	0.016%	163
	Benjamin Heyny	312,500	0.456%	4,561
	Alois Hofbauer	28,152	0.041%	411
	Jurgen Horbauer	84,288	0.123%	1,230
	Thomas Hofbauer	28,169	0.041%	411
	Michael Hofer	112,188	0.164%	1,637
	Maximilian Horhager	28,475	0.042%	416
	Birgit Kirchner	15,996	0.023%	233
	Pascal Kitzmuller	13,900	0.020%	203
	Christoph Klein	26,783	0.039%	391
	Anton Krapf	42,410	0.062%	619
	Stephan Lukas Podlipnig	176,050	0.257%	2,570
	Stefan Mang	35,133	0.051%	513
	Wolfgang Martinschitz	499,312	0.729%	7,288
	Wolfgang Mayerhofer	70,659	0.103%	1,031
	Steffi McCown	167,500	0.244%	2,445




    Page 17 of 18


     


    

 


	Claudia Monay	14,000	0.020%	204
	Christian Monninghoff	250,000	0.365%	3,649
	Thomas Morak	21,087	0.031%	308
	Jan Niklas Hadler	27,962	0.041%	408
	Marc Oliver Richter	150,000	0.219%	2,189
	Kurt Ortner	71,065	0.104%	1,037
	Jan Papenbrock	250,000	0.365%	3,649
	Mike Pfeiffer	28,088	0.041%	410
	David Podlipnig	350,738	0.512%	5,119
	Johann Podlipnig	350,988	0.512%	5,123
	Sabrina Podlipnig	176,050	0.257%	2,570
	Michael Putz	1,000,000	1.460%	14,595
	Mario Reichmuth	8,149	0.012%	119
	Dirk Richter	20,000,000	29.191%	291,906
	Thomas Richter	150,000	0.219%	2,189
	Robert Rieder	150,000	0.219%	2,189
	Alexander Rudiger	98,513	0.144%	1,438
	Andreas Sammer	150,000	0.219%	2,189
	Bernhard Sammer	20,000,000	29.191%	291,906
	Josef Sammer	150,000	0.219%	2,189
	Zeliko Sekulic	1,000,000	1.460%	14,595
	Rene Simmen	12,675	0.018%	185
	Stella Soldner	13,800	0.020%	201
	Hannes Sommer	2,000,000	2.919%	29,191
	Hannes Sommer	3,000,000	4.379%	43,786
	Thomas Stangl	84,469	0.123%	1,233
	Dietmar Thuller	346,796	0.506%	5,062
	Thomas Tork	280,375	0.409%	4,092
	Hanna Valeisha	150,000	0.219%	2,189
	Helga Wagner	68,556	0.100%	1,001
	Thomas Waldher	42,405	0.062%	619
	Marcus Weissenbock	28,250	0.041%	412
	Karl Weixelbaumer	70,080	0.102%	1,023
	Bernhard Zimmerl	35,330	0.052%	516
	Bernhard Zimmerl	35,012	0.051%	511
	Erich Zullig	100,000	0.146%	1,460
	Jurg Zullig	25,787	0.038%	376
	 	 	 	 
	TOTAL	68,515,124	1.0000	1,000,000



 



    Page 18 of 18